Hospitals
Toronto is home to more than 30 hospitals, including leading academic medical centers and highly specialized institutions. Many of these facilities operate within large healthcare networks that span multiple locations across the city.
Description
As a premier global destination for health innovation, Toronto’s life sciences ecosystem stands as North America’s largest urban research cluster, anchored by the world-renowned Discovery District. The city is a powerhouse in biotechnology and pharmaceutical R&D, famously known as the birthplace of insulin and the stem cell, while currently leading the charge in regenerative medicine and cell and gene therapies. T
oronto’s academic research is fueled by the University of Toronto, consistently ranked among the top 10 globally for medical and health sciences, and supported by nine major teaching hospitals within the University Health Network (UHN). This dense concentration of clinical excellence fosters a unique environment for healthcare innovation, where AI-driven drug discovery startups like Deep Genomics and BenchSci thrive alongside global pharma giants like Sanofi and Johnson & Johnson. The MaRS Discovery District serves as a vital innovation hub, bridging the gap between laboratory breakthroughs and commercialization for high-growth medtech and digital health ventures.
Investors and talent are drawn to the region’s robust pipeline of clinical trials and its sophisticated medical device manufacturing sector, which includes leaders in surgical robotics and diagnostics.
Facilitated by initiatives like Life Sciences Central, the ecosystem offers seamless access to wet lab space, venture capital, and specialized talent. With a workforce of over 30,000 professionals, Toronto continues to define the future of personalized medicine and precision oncology.
This collaborative synergy between government, industry and academia ensures Toronto remains a top-tier destination for global life sciences investment and transformative health solutions.
Featured Editorial
Regions
Universities
Toronto’s life sciences ecosystem is anchored by several Tier‑1 research institutions, with the University of Toronto (UofT) being the major driver of health research in the city. It has over $1 billion in research funding across universities and partner hospitals. Toronto Metropolitan University, York University, McMaster University (satellite campuses) and specialized colleges are other notable academic institutions with a significant life sciences focus.
Government Funding
The Canadian Institutes of Health Research (CIHR), Canada’s main federal health research agency, reported its grants and awards expenditure in 2024-2025 to be just over $1.3 billion. Meanwhile, the province of Ontario has been ramping up life sciences investment through new funding and global partnerships. The province renewed its Life Sciences Innovation Fund, helping 30 companies attract $63 million in investment, and committed $146 million under its Life Sciences Strategy. Invest Ontario has backed major projects like AstraZeneca’s $570 million expansion and Roche’s $130 million informatics hub, creating hundreds of new jobs.
VC Funding
While no specific data for Toronto is available, in 2024, Canadian life sciences companies secured a total of $1.38 billion in venture capital across 128 deals, according to data from the Canadian Venture Capital & Private Equity Association.
Life Science Firms
The Toronto Region hosts more than 1,400 life sciences organizations, making it the most concentrated hub of life sciences activity among Canadian metropolitan areas.
Big Pharma Presence
The Greater Toronto Area (GTA) is home to a strong big pharma presence. Global players such as Sanofi, AstraZeneca, Roche, GSK, Amgen, Gilead, Bayer and Takeda operate in the region. Apotex, Canada’s largest generic drug maker, also has major operations in Toronto.
Big Medtech Presence
Examples of Toronto-based medtech companies include Able Innovations, Synaptive Medical, Flosonics Medical and others.
Active Clinical Studies
There are currently over 2,928 active clinical trials in Toronto.
